SCHEMBL5265183

SCHEMBL5265183

O=c1c(Cl)c(CCN2CCN(c3ccc(O)cc3)CC2)[nH]n1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 2/20 0.48
HTR7 P34969 4/20 0.45
HTR1A P08908 3/20 0.45
DRD2 P14416 1/20 0.45
SIGMAR1 Q99720 2/20 0.44
MAPT P10636 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ADRA1D P25100 3/20 0.43
ADRA1A P35348 3/20 0.43
ADRA1B P35368 3/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
ME2 P23368 1/20 0.42
ME1 P48163 1/20 0.42
ME3 Q16798 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5265038 0.89 OPRM1 (0.54) DRD4HTR7HTR1ADRD2SIGMAR1
SCHEMBL5265027 0.84 DRD4 (0.47) DRD4HTR7HTR1ADRD2SIGMAR1
SCHEMBL5264783 0.81 DRD2 (0.51) DRD4HTR7HTR1ADRD2
SCHEMBL5266680 0.81 SLC6A2 (0.47) DRD4HTR7HTR1ADRD2SIGMAR1
SCHEMBL5268003 0.80 SIGMAR1 (0.53) HTR7HTR1ASIGMAR1MEN1KMT2A
SCHEMBL5263985 0.80 SIGMAR1 (0.47) HTR7HTR1ASIGMAR1MEN1KMT2A
SCHEMBL5263941 0.79 MEN1 (0.57) HTR7HTR1ADRD2MAPTADRA1D
SCHEMBL5265422 0.79 ADRA1D (0.57) HTR7HTR1ADRD2ADRA1DADRA1A
SCHEMBL5270524 0.79 MEN1 (0.54) DRD4HTR7HTR1ADRD2MAPT
SCHEMBL4318159 0.78 ALDH1A1 (0.48) DRD4HTR7HTR1ADRD2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833800-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006071730-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2006-07-06 WO disclosed